Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...

President - Merck Research Laboratories; Merck & Co Inc Thank you for standing by. Welcome to the Merck and Company Q4 sales and earnings conference call. (Operator Instructions) This call is being ...

Dr. Dean Li, President, Merck Research Laboratories, would no doubt disagree. In a webcast to analysts, Li noted that in 2024 more than 20 Phase 3 studies were initiated in multiple therapeutic areas.

Merck Foundation and First Ladies of Africa mark World Cancer Day 2025: 194 Oncology Scholarships Provided Across 32 African Countries ...

India], January 4: Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks ‘World Cancer Day 2025’ together with ...

Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, ...

Ugandan authorities launched on Monday a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one ...

Expert Rev Endocrinol Metab. 2013;8(5):423-425. "…there is now substantial evidence that T2D is an independent risk factor for fractures." As the incidence of diabetes continues to increase, it ...